Nearly four in 10 workers’ compensation claims with significant lost time received injectable therapies within two years of injury, yet payments varied dramatically by state—from as low as $362 in California to as much as $2,404 in Louisiana—according to a Workers Compensation Research Institute study.

Injectable therapies are offered as valuable alternatives to invasive surgeries and addictive oral pain medications, but there is little data on their use and costs in workers’ compensation, the WCRI noted. The study, based on data from 28 states, found that 39% of claims with more than seven days of lost time received at least one injectable therapy at an average cost of $872 per claim.

Read the full article here.  The newly-released WCRI study is Injectable Therapies in Workers’ Compensation.  You can find more information, including details on how to download a copy, elsewhere on our website; we also have a video about the study!